Follow-Up and Management of Patients With Head and Neck Cancer During the 2019 Novel Coronavirus (SARS-CoV-2) Disease Pandemic

Uptake of telepractice among speech-language therapists following COVID-19 pandemic in India

“…The declaration of a pandemic due to the spread of Coronavirus disease 2019 (COVID-19) has led to drastic changes in service delivery by healthcare professionals. Various professionals have adapted to changing times and are providing their services via telepractice during this pandemic (Arneson, Tucker, Mercier, & Singh, 2020;Chua et al, 2020;Moccia et al, 2020). The Government and Professional Associations have also stepped forward by updating guidelines or relaxation of licensing for telepractice (American Speech-Language and Hearing Association (ASHA), 2020a; Facher, 2020; Ministry of Health and Family Welfare (MoHFW) 2020).…”

Microbial strategies for degradation of microplastics generated from COVID-19 healthcare waste

“…The COVID-19 medical waste largely comprises PPE kits, disposable masks, gloves and other associated protective wear containing plastics which were extensively used during the pandemic. These PPE kits and disposable masks are made up of high-density polyethylene and polypropylene which are mainly produced by non-woven fabrics ( Chua et al, 2020 ). Apart from polypropylene, other polymers, such as polyester, polyethylene, polystyrene or polycarbonate are also used for making the masks ( Akber Abbasi et al, 2020 ).…”

Proton Therapy in a Pandemic: An Operational Response to the COVID-19 Crisis

“…With these interventions, the number of patients treated at the PTC with proton therapy decreased from 116 on March 2 to 78 on March 31, 2020, a 33% reduction in clinical volume. New patients who started treatment tended to have life-threating tumors, such as head and neck tumors [ 4 ], thoracic tumors, and as pediatric malignancies [ 5 ] where treatment delay would likely have a negative effect on outcomes. These were also patients for whom radiation therapy could not be deferred or delayed without compromising clinical outcomes.…”